Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Analysis of the Cytomegalovirus Proteome Reveals Unanticipated Complexity

By LabMedica International staff writers
Posted on 05 Dec 2012
Advanced genomic and proteomic analysis techniques have been used for an in-depth study of the proteome of human Cytomegalovirus (HCMV), an incredibly successful pathogen that infects nearly everyone.

The huge 240,000 base pair HCMV genome was sequenced more than 20 years ago, but the viral proteome (the proteins encode by those genes) has not been studied in a comprehensive fashion.

Investigators at the University of California, San Francisco (USA) have now obtained much of the missing proteomic data. They used state-of-the-art ribosome profiling and transcript analysis linked to mass spectrometry to experimentally define the HCMV translation products (proteins) and follow their temporal expression. In translation, messenger RNA (mRNA) produced by transcription is decoded by the ribosomes to produce specific polypeptides that will later fold into active proteins.

Ribosome profiling is a technique that uses mRNA to determine what proteins are being translated. It produces a “global snapshot” of all the ribosomes active in the cell at a particular moment. Consequently, this enables researchers to identify the location of translation start sites, their distribution, and the speed of the translating ribosomes. Ribosome profiling derived from the old discovery that the mRNA within a ribosome can be isolated through the use of nucleases that degrade unprotected mRNA regions. This technique analyzes the ratio of multiple specific mRNAs to proteins being synthesized, to provide insight into global gene expression.

Results published in the November 23, 2012, issue of the journal Science revealed hundreds of previously unidentified open reading frames (sites of protein translation), a fraction of which were confirmed by means of mass spectrometry. Many of these open reading frames were found to encode for exceptionally short protein sequences (fewer than 100 amino acids), and some of the newly identified open reading frames were sequestered inside other open reading frames.

These results unveiled an unanticipated complexity to the HCMV coding capacity and illustrated the role of the regulated use of alternative transcript start sites in enabling tight temporal control of HCMV protein expression and allowing multiple distinct polypeptides to be generated from a single genomic locus.

"The genome of a virus is just a starting point," said senior author Dr. Jonathan Weissman, professor of cellular and molecular pharmacology and of biochemistry and biophysics at the University of California, San Francisco. "Understanding what proteins are encoded by that genome allows us to start thinking about what the virus does and how we can interfere with it… Each of the proteins we have identified has the potential to tell us how this virus is manipulating its host cell."

Related Links:
University of California, San Francisco


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.